Clinical trial
Enteroaggregative E.Coli (EAEC)
NCT00362869 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00362869 |
|---|---|
| Title | Enteroaggregative E.Coli (EAEC) |
| Official title | Pathogenicity of Enteroaggregative E. Coli in Adult Volunteers; Dose-Escalation Study |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Escherichia Coli Infections |
| Intervention type | Biological, Drug |
| Interventions | Levofloxacin, Placebo, Enteroaggregative E. coli (EAEC) |
| Enrollment | 5 |
| Start date | Feb 1, 2008 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 15, 2006 |
| Last update posted | Dec 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: